HyProCure for progressive collapsing foot deformity: is subtalar arthroereisis a good procedure?

Abstract Purpose To investigate the treatment outcomes of subtalar arthroereisis (SA) in progressive collapsing foot deformity (PCFD) patients, to assess the clinical efficacy in PCFD patients after HyProCure removal, and to evaluate safety and effectiveness of SA. Methods In this retrospective stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Shaoling Fu, Cheng Wang, Shutao Zhang, Chenglin Wu, Jiazheng Wang, Zhongmin Shi
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-024-05406-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850085988150280192
author Shaoling Fu
Cheng Wang
Shutao Zhang
Chenglin Wu
Jiazheng Wang
Zhongmin Shi
author_facet Shaoling Fu
Cheng Wang
Shutao Zhang
Chenglin Wu
Jiazheng Wang
Zhongmin Shi
author_sort Shaoling Fu
collection DOAJ
description Abstract Purpose To investigate the treatment outcomes of subtalar arthroereisis (SA) in progressive collapsing foot deformity (PCFD) patients, to assess the clinical efficacy in PCFD patients after HyProCure removal, and to evaluate safety and effectiveness of SA. Methods In this retrospective study, 202 cases (213 feet) of PCFD patients treated with SA from June 2015 to December 2022 were selected. General data and surgical information were recorded, and clinical efficacy was evaluated through imaging and clinical indicators. Furthermore, for 36 patients (36 feet) who underwent secondary surgery to remove HyProCure, imaging and clinical evaluation indicators at 1-year post-removal were recorded. Complications were also documented. Results The main complications were sinus tarsi pain (91.37%), with partial relief or disappearance of symptoms in some patients after conservative treatment. The imaging indicators improved significantly after SA (P < 0.01), and AOFAS score and VAS were significantly improved (P < 0.01), with a 100% excellent rate in patients one year after SA. For patients who removed HyProCure, the imaging indicators exhibited a significant improvement at preoperation and post-SA (P < 0.01), and no statistical difference was observed between post-SA and post-removal (P > 0.05). Regarding clinical indicators, AOFAS score at post-SA was difference compared with preoperation and post-removal separately (P < 0.01). However, the difference in VAS between preoperation and post-SA was not statistically significant (P > 0.05). Notably, there was a significant improvement at post-removal compared with post-SA (P < 0.01). Conclusion PCFD patients showed significant improvement in imaging and clinical evaluations after SA, with no significant flatfoot recurrence in patients who had HyProCure removed. Therefore, the application of HyProCure in SA can be considered a safe and effective surgical treatment for PCFD patients.
format Article
id doaj-art-23fe7a8f3dbd4aefbc5d6956114d1a87
institution DOAJ
issn 1749-799X
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj-art-23fe7a8f3dbd4aefbc5d6956114d1a872025-08-20T02:43:36ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2024-12-0119111110.1186/s13018-024-05406-3HyProCure for progressive collapsing foot deformity: is subtalar arthroereisis a good procedure?Shaoling Fu0Cheng Wang1Shutao Zhang2Chenglin Wu3Jiazheng Wang4Zhongmin Shi5Department of Orthopedic Surgery, Shanghai Sixth People’s HospitalDepartment of Orthopedic Surgery, Shanghai Sixth People’s HospitalDepartment of Orthopedic Surgery, Shanghai Sixth People’s HospitalDepartment of Orthopedic Surgery, Shanghai Sixth People’s HospitalDepartment of Orthopedic Surgery, Shanghai Sixth People’s HospitalDepartment of Orthopedic Surgery, Shanghai Sixth People’s HospitalAbstract Purpose To investigate the treatment outcomes of subtalar arthroereisis (SA) in progressive collapsing foot deformity (PCFD) patients, to assess the clinical efficacy in PCFD patients after HyProCure removal, and to evaluate safety and effectiveness of SA. Methods In this retrospective study, 202 cases (213 feet) of PCFD patients treated with SA from June 2015 to December 2022 were selected. General data and surgical information were recorded, and clinical efficacy was evaluated through imaging and clinical indicators. Furthermore, for 36 patients (36 feet) who underwent secondary surgery to remove HyProCure, imaging and clinical evaluation indicators at 1-year post-removal were recorded. Complications were also documented. Results The main complications were sinus tarsi pain (91.37%), with partial relief or disappearance of symptoms in some patients after conservative treatment. The imaging indicators improved significantly after SA (P < 0.01), and AOFAS score and VAS were significantly improved (P < 0.01), with a 100% excellent rate in patients one year after SA. For patients who removed HyProCure, the imaging indicators exhibited a significant improvement at preoperation and post-SA (P < 0.01), and no statistical difference was observed between post-SA and post-removal (P > 0.05). Regarding clinical indicators, AOFAS score at post-SA was difference compared with preoperation and post-removal separately (P < 0.01). However, the difference in VAS between preoperation and post-SA was not statistically significant (P > 0.05). Notably, there was a significant improvement at post-removal compared with post-SA (P < 0.01). Conclusion PCFD patients showed significant improvement in imaging and clinical evaluations after SA, with no significant flatfoot recurrence in patients who had HyProCure removed. Therefore, the application of HyProCure in SA can be considered a safe and effective surgical treatment for PCFD patients.https://doi.org/10.1186/s13018-024-05406-3Subtalar arthroereisisProgressive collapsing foot deformityTreatment outcomeFlatfootHyProCure
spellingShingle Shaoling Fu
Cheng Wang
Shutao Zhang
Chenglin Wu
Jiazheng Wang
Zhongmin Shi
HyProCure for progressive collapsing foot deformity: is subtalar arthroereisis a good procedure?
Journal of Orthopaedic Surgery and Research
Subtalar arthroereisis
Progressive collapsing foot deformity
Treatment outcome
Flatfoot
HyProCure
title HyProCure for progressive collapsing foot deformity: is subtalar arthroereisis a good procedure?
title_full HyProCure for progressive collapsing foot deformity: is subtalar arthroereisis a good procedure?
title_fullStr HyProCure for progressive collapsing foot deformity: is subtalar arthroereisis a good procedure?
title_full_unstemmed HyProCure for progressive collapsing foot deformity: is subtalar arthroereisis a good procedure?
title_short HyProCure for progressive collapsing foot deformity: is subtalar arthroereisis a good procedure?
title_sort hyprocure for progressive collapsing foot deformity is subtalar arthroereisis a good procedure
topic Subtalar arthroereisis
Progressive collapsing foot deformity
Treatment outcome
Flatfoot
HyProCure
url https://doi.org/10.1186/s13018-024-05406-3
work_keys_str_mv AT shaolingfu hyprocureforprogressivecollapsingfootdeformityissubtalararthroereisisagoodprocedure
AT chengwang hyprocureforprogressivecollapsingfootdeformityissubtalararthroereisisagoodprocedure
AT shutaozhang hyprocureforprogressivecollapsingfootdeformityissubtalararthroereisisagoodprocedure
AT chenglinwu hyprocureforprogressivecollapsingfootdeformityissubtalararthroereisisagoodprocedure
AT jiazhengwang hyprocureforprogressivecollapsingfootdeformityissubtalararthroereisisagoodprocedure
AT zhongminshi hyprocureforprogressivecollapsingfootdeformityissubtalararthroereisisagoodprocedure